Literature DB >> 1666122

Biochemical changes within a multiple sclerosis plaque in vivo.

T A Cadoux-Hudson1, A Kermode, B Rajagopalan, D Taylor, A J Thompson, I E Ormerod, W I McDonald, G K Radda.   

Abstract

Magnetic resonance spectroscopy (MRS) was performed on a superficial part of the brain containing a large multiple sclerosis (MS) lesion. Reduced levels of phosphocreatine (PCr) relative to adenosine triphosphate (ATP) were found suggesting an abnormality in energy metabolism, with an increase in the phosphodiester (PDE) peak. A follow up study 16 months later revealed reduction in size of the lesion on MRI and normal intracellular biochemistry by MRS. Four MS patients without visible superficial cerebral lesions showed no significant changes in phosphorus metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666122      PMCID: PMC1014626          DOI: 10.1136/jnnp.54.11.1004

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Creatine uptake, metabolism, and efflux in human monocytes and macrophages.

Authors:  J D Loike; M Somes; S C Silverstein
Journal:  Am J Physiol       Date:  1986-07

2.  Passive electrical isolation of double coil probes for localized spectroscopy and imaging.

Authors:  P Styles
Journal:  NMR Biomed       Date:  1988-04       Impact factor: 4.044

3.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.

Authors:  D J Taylor; P J Bore; P Styles; D G Gadian; G K Radda
Journal:  Mol Biol Med       Date:  1983-07

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Phospholipid bilayer contribution to 31P NMR spectra in vivo.

Authors:  E J Murphy; B Rajagopalan; K M Brindle; G K Radda
Journal:  Magn Reson Med       Date:  1989-11       Impact factor: 4.668

6.  Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR.

Authors:  M J Blackledge; B Rajagopalan; R D Oberhaensli; N M Bolas; P Styles; G K Radda
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Multiple sclerosis: a serial study using MRI in relapsing patients.

Authors:  C Isaac; D K Li; M Genton; C Jardine; E Grochowski; M Palmer; L F Kastrukoff; J Oger; D W Paty
Journal:  Neurology       Date:  1988-10       Impact factor: 9.910

8.  Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

Authors:  A G Kermode; P S Tofts; A J Thompson; D G MacManus; P Rudge; B E Kendall; D P Kingsley; I F Moseley; E P du Boulay; W I McDonald
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

9.  The use of NMR spectroscopy for the understanding of disease.

Authors:  G K Radda
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

10.  Human primary brain tumour metabolism in vivo: a phosphorus magnetic resonance spectroscopy study.

Authors:  T A Cadoux-Hudson; M J Blackledge; B Rajagopalan; D J Taylor; G K Radda
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more
  4 in total

Review 1.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

Review 2.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

Review 3.  Current Methods of Magnetic Resonance for Noninvasive Assessment of Molecular Aspects of Pathoetiology in Multiple Sclerosis.

Authors:  Petra Hnilicová; Oliver Štrbák; Martin Kolisek; Egon Kurča; Kamil Zeleňák; Štefan Sivák; Ema Kantorová
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

Review 4.  Low Tissue Creatine: A Therapeutic Target in Clinical Nutrition.

Authors:  Sergej M Ostojic
Journal:  Nutrients       Date:  2022-03-15       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.